Add 2 More Reports For 20% off

Report Overview

The global AI in clinical trials market was valued at USD 1.80 Billion in 2023, driven by rising requirements to overcome data limitations across the globe. It is expected to grow at a CAGR of 14.00% during the forecast period 2024-2032, and attain a market value of USD 5.85 Billion by 2032.

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

  • Strategic partnerships, such as the one between Deep 6 AI and Texas Tech University Health Sciences Center (TTUHSC), established in August 2023, are part of a growing trend to integrate artificial intelligence with electronic medical records (EMR) to streamline patient access to clinical trials.
  • In November 2023, AstraZeneca launched Evinova, a health technology company that aims to offer digital health solutions to speed up clinical trial processes and decrease costs. The launch of such new health tech ventures focused on leveraging digital solutions to optimize clinical research efficiency is anticipated to boost market size.
  • The growing focus on patient-centric trial designs and the increasing regulatory support for AI-driven clinical trials are expected to elevate the market value in the forecast period.

AI in Clinical Trials Market Overview

AI technology, combined with big data, can tackle major obstacles in clinical trials by processing and examining large volumes of data. AI and advanced analytics can enhance productivity in clinical R&D by merging trial phases, developing patient-focused endpoints, and examining real world data. Increased participation of AI in drug research and development is expected to fuel market growth. Additionally, the market is impacted by the increasing emphasis on diversity and inclusivity.

AI in Clinical Trials Market Growth Drivers

Artificial Intelligence (AI) in Drug Research and Development to Drive Market Growth

Advancements in technology and artificial intelligence are driving growth in the field of drug research and development. A July 2024 update demonstrates how AI and data analytics are reducing time and costs for introducing medications to the market, improving efficiency in clinical trials, managing data complexities, and optimizing technological investments in the biopharmaceutical industry.

AI in Clinical Trials Market Trends

AI in Clinical Trials Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Phase

  • Phase I
  • Phase II
  • Phase III

Market Breakup by Application

  • Oncology
  • Neurology Diseases
  • Cardiological Diseases
  • Infectious Disease
  • Immunological Diseases
  • Others

Market Breakup by End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Academic and Research Institutes
  • Cancer Centers
  • Others

Market Breakup by Region

  • North America 
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

AI in Clinical Trials Market Share

Market Segmentation Based on the Application to Witness Growth

Based on the application, the market for AI in clinical trials is segmented into oncology, neurology diseases, cardiological diseases, infectious diseases, immunological diseases, and others. The infectious disease segment is expected to dominate the market share as AI allows for the effective processing and analysis of complex data sets, helping researchers gain new insights and make defensible conclusions in clinical studies.

AI in Clinical Trials Market Analysis by Region

Based on region, the market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America, especially the United States, is at the forefront of AI innovation and technology, leading the AI in clinical trials market. This dominance is driven by the presence of major IT companies, educational institutions, and new startups dedicated to developing and advancing AI technologies for various sectors.

Leading Players in the AI in Clinical Trials Market

The key features of the market report include patent analysis, grant analysis, funding, and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Unlearn.ai, Inc.

Unlearn.AI is a healthcare AI company that develops AI to speed up drug development and remove trial and error in medicine using digital twins.

Saama

Saama, is a consulting and systems integration firma platform for clinical analytics powered by AI, presents G...

Antidote Technologies, Inc.

Antidote is a digital health company that employs artificial intelligence and digital technologies to improve ...

Phesi

Phesi, a United States-based company specializing in data infrastructure and analytics for clinical trials, pr...

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other key players in the market include Deep6.ai, Innoplexus, Intelligencia AI, Median Technologies, and Consilx.

Key Questions Answered in the AI in Clinical Trials Market Report

  • What was the AI in clinical trials market value in 2023?
  • What is the AI in clinical trials market forecast outlook for 2024-2032?
  • What are the regional markets covered in the EMR report?
  • What is the market segmentation based on application?
  • What is the market segmentation based on phase?
  • What is the market breakup based on the end user?
  • What are the major factors aiding the AI in clinical trials market demand?
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the major drivers, opportunities, and restraints in the market?
  • What are the major trends influencing the market?
  • Which regional market is expected to dominate the market share in the forecast period?
  • Which country is likely to experience elevated growth during the forecast period?
  • Who are the key players involved in the AI in clinical trials market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Phase
  • Application
  • End User
  • Region
Breakup by Phase
  • Phase I
  • Phase II
  • Phase III
Breakup by Application
  • Oncology
  • Neurology Diseases
  • Cardiological Diseases
  • Infectious Disease
  • Immunological Diseases
  • Others
Breakup by End User
  • Pharmaceutical and Biopharmaceutical Companies
  • Academic and Research Institutes
  • Cancer Centers
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • Unlearn.ai, Inc.
  • Saama
  • Antidote Technologies, Inc.
  • Phesi
  • Deep6.ai
  • Innoplexus
  • Intelligencia AI
  • Median Technologies
  • Consilx

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124